Ulla Grove Krogsgaard Thomsen is the CEO of Novo Nordisk Pharmatech A/S, where they lead with a purpose-driven entrepreneurial style that has successfully brought innovative drugs to market. With extensive experience in the life science sector, Ulla has previously held the role of Corporate Vice President at Novo Nordisk, overseeing significant production and research initiatives. Recognized as the Life Science Executive of the Year in 2022, Ulla also serves on various boards, contributing insight and leadership in transformative business strategies. Currently, Ulla is advancing their education through multiple executive programs from prestigious institutions such as Harvard Business School and INSEAD.